The Penn CFAR represents a collaboration among the University of Pennsylvania, The Children's Hospital of Philadelphia, and The Wistar Institute. This Center is committed to the principles laid out in the National CFAR Mission Statement and strives to create a highly interactive environment among faculty on campus engaged in HIV/AIDS research. The Administrative Core (Core A) conducts, coordinates, and monitors activities of the Center to build infrastructure that fosters interdisciplinary and translational research in HIV/AIDS by establishing shared resource Core facilities, educational activities, and a Developmental Grants program in basic, clinical, behavioral and social sciences. The Administrative Core is also deeply committed to initiatives that build strong ties to the campus and the community. The Administrative will continue to be directed by James Hoxie. Ronald Collman assumed the role as CFAR Co-Director as of November 1, 2007. when Francisco Gonzalez-Scarano stepped down to attend to his responsibilities as Chair of Neurology and Co-Director of the Penn Comprehensive Neurosciences Center. The Director's and Co-Director's leadership oversees a governing Executive Committee and four Scientific Programs: Virology/Pathogenesis (Director, Robert Doms and Co-Director, Guido Silvestri);Clinical/Therapeutics (Director, Ian Frank;and Co-Director, Pablo Tebas);Immunology/Vaccine (Director, David Weiner;and Co-Director, Terri Finkel);and Behavioral &Social Sciences (Director, David Metzger). The Administrative Core implements the overall mission of the CFAR in association with the Executive Committee and with assistance from an External Advisory Committee and an Internal Advisory Board. The Administrative Core provides the management and scientific direction for the CFAR and establishes the necessary linkages among participants from the Center's three institutions. The goals of this Core continue to be 1) to facilitate communication that fosters collaborations between CFAR members;2) to ensure that opportunities in emerging scientific areas and technologies in HIV/AIDS research are recognized and pursued;3) to ensure that shared Core facilities serve the research needs of participating members and comply with the policies by which they were established;4) to ensure sound fiscal management and accountability for CFAR Core activities and Developmental funds;5) to establish multidisciplinary educational programs for faculty and students;and 6) to work with the Behavioral &Social Sciences (F) and International (I) Cores to develop strong outreach programs that address the needs of domestic and international populations most affected by the HIV epidemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-14
Application #
8377885
Study Section
Special Emphasis Panel (ZAI1-SV-A)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
14
Fiscal Year
2012
Total Cost
$376,887
Indirect Cost
$126,998
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79
Gowda, Charitha; Lott, Stephen; Grigorian, Matthew et al. (2018) Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study. Open Forum Infect Dis 5:ofy076
Clarke, Erik L; Connell, A Jesse; Six, Emmanuelle et al. (2018) T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. Genome Med 10:70
Coviello, D M; Lovato, R; Apostol, K et al. (2018) Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders. Community Ment Health J :
Martei, Yehoda M; Pace, Lydia E; Brock, Jane E et al. (2018) Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge. Clin Lab Med 38:161-173
Ojikutu, Bisola O; Bogart, Laura M; Higgins-Biddle, Molly et al. (2018) Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav 22:3576-3587
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Wood, Sarah; Ratcliffe, Sarah; Gowda, Charitha et al. (2018) Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV. AIDS 32:895-902
Shin, S S; Modongo, C; Zetola, N M et al. (2018) High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana. Int J Tuberc Lung Dis 22:366-370
Genn, Leah; Chapman, Jennifer; Okatch, Harriet et al. (2018) Pharmacy Refill Data are Poor Predictors of Virologic Treatment Outcomes in Adolescents with HIV in Botswana. AIDS Behav :

Showing the most recent 10 out of 775 publications